SCWorx Corp. received a partial compliance letter from the Nasdaq Hearings Panel confirming it met the first condition of its plan to regain listing on The Nasdaq Capital Market, which required shareholder approval for a reverse stock split by July 22, 2026. The company must now effectuate the reverse stock split by August 3, 2026, and demonstrate a closing bid price of at least $1.00 per share for twenty consecutive trading days by August 28, 2026. SCWorx operates in the healthcare technology industry, providing data normalization and supply chain solutions.
